FDA Grants 23andMe Approval to Sell Test for a Rare Genetic Condition
At the end of 2013, 23andme was ordered to stop selling its DNA testing kit health reports by the Food and Drug Administration. Now, the FDA has granted the company approval to sell a single test for the markers of Bloom Syndrome, a rare genetic disease. Bloom Syndrome is associated with short stature, sun sensitivity,…